Pharco Pharmaceuticals

Establishment of Pharco Impex 93, which is the import, marketing, and distribution branch of Pharco in Romania. Majority partner shares in Pharco Pharmaceuticals were acquired by Dr. Launch of Pharco B International, starting with a dedicated facility for the production of Cephalosporin antibiotics for local and international markets. A separate Extension in Pharco B International for the production of water for injection in plastic ampoule. At Pharco B International was established to produce small and large volume parenteral. Gamal Esmat, representing Pharco, was the first Arab to present at the closing ceremony, where the major treatment protocols for the upcoming year are agreed upon. Pharco established the first GMP compliant Active Pharmaceutical Ingredients (API) factory in Egypt in 2015 starting in April 2016 with the production of Sofosbuvir with a non-infringing method. Accordingly, Pharco created the first API factory in Egypt (Active Pharmaceutical Ingredients) specialized in manufacturing of modern Hepatitis C therapies which are relatively affordable and efficient, all per cGMP requirements.